Clinical Trials Browser

Observational × Leukemia × blinatumomab × Clear all

NCT06649422 2024-10-18

Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

Not yet recruiting

Other hematologic neoplasm

Leukemia